Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae245 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Sorush Rokui und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, St Paul's Hospital and University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Mitral Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES Prothesis choice in isolated mitral valve replacement for patients aged 75 years or younger remains debated as most studies comparing prothesis type have included large proportions of combined operations and benefits are influenced by concomitant procedures. This study compared long-term outcomes of isolated mechanical versus bioprosthetic mitral valves in different age groups of propensity-matched populations. METHODS This is a retrospective, multicentre, propensity-matched observational study. Baseline characteristics, operative details and long-term outcomes (mortality and freedom from surgical/transcatheter reintervention) were collected. RESULTS Totally, 1536 isolated mitral valve replacements (806 mechanical, 730 bioprosthetic) were performed between 2000 and 2017. Over 90% of eligible patients successfully underwent propensity matching, yielding 226 each of mechanical and bioprosthetic valves in patients aged <65 years and 171 each of bioprosthetic and mechanical valves in patients aged 65–75 years with median follow-up of 13 years (maximum 20 years). In matched patients <65 years, 10-year survival was superior with mechanical valves versus bioprosthetic valves (78.2% vs 69.8%, P = 0.029), as was 10-year freedom from reintervention (96.2% vs 81.3%, P < 0.001). For matched patients between 65 and 75 years, there were no differences between mechanical and bioprosthetic valves in 10-year survival (64.6% vs 60.8%, P = 0.86) or 10-year freedom from reintervention (94.0% vs 97.2%, P = 0.23). Rates of post-operative stroke, gastrointestinal bleeding, renal failure and permanent pacemaker insertion were similar. CONCLUSIONS In patients requiring isolated mitral valve replacement, mechanical valves confer significantly better long-term survival and freedom from reintervention for patients <65 years, while no benefit is observed at age 65–75 years compared to bioprosthetic valves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, St Paul's Hospital and University of British Columbia, Vancouver, BC, Canada.
- Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, BC, Canada.
ORCID-Profile: Sorush Rokui, Jian Ye
Zitieren
APA
Rokui, S., Gottschalk, B., Peng, D., Groenewoud, R., & Ye, J. (2024). Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae245
Vancouver
Rokui S, Gottschalk B, Peng D, Groenewoud R, Ye J. Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae245
BibTeX
@article{Rokui2024,
author = {Rokui, Sorush and Gottschalk, Byron and Peng, Defen and Groenewoud, Rosalind and Ye, Jian},
title = {Long-term outcomes of isolated mechanical versus bioprosthetic mitral valve replacement in different age groups of propensity-matched patients},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae245}
}
EUVIMED